ALG-LungCancerRegistry (SAFRO2202)

RecruitingOBSERVATIONAL
Enrollment

3,750

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small CellCarcinoid Tumor
Interventions
OTHER

Observational Data Collection

Collection of clinical, pathological, molecular, and treatment-related data during routine care, with no additional procedures or interventions required by the study.

Trial Locations (21)

15100

RECRUITING

CLCC Draâ Ben Khedda, Tizi Ouzou

16000

RECRUITING

Centre Pierre et Marie Curie, Algiers

RECRUITING

Chu Beni Messous - Isaad Hassani, Algiers

RECRUITING

CHU Mohamed Lamine Debaghine - Bab-el-Oued, Algiers

RECRUITING

Chu-Beni Messous - Isaad Hassani, Algiers

RECRUITING

EPH Rouiba, Algiers

19000

RECRUITING

CAC-Sétif, Sétif

22000

RECRUITING

CAC- Sidi Bel Abbès, Sidi Bel Abbes

23000

RECRUITING

CLCC Annaba, Annaba

25000

RECRUITING

CHU Dr Abdesselam Benbadis, Constantine

RECRUITING

EH Didouche Mourad, Constantine

30000

RECRUITING

CAC- Ouargla, Ouargla

31000

RECRUITING

CAC Oran EL HASSI- EMIR ABDELKADER, Oran

RECRUITING

CHU Dr. Benaouda Benzerdjeb, Oran

RECRUITING

EHS 1er novembre, Oran

39000

RECRUITING

CAC El OUED, El Oued

42115

RECRUITING

EPH- Sidi Ghiles, Tipasa

Unknown

RECRUITING

CLCC Batna, Batna City

RECRUITING

CAC-CHU Frantz Fanon, Blida

06000

RECRUITING

CHU- Hôpital Khelil Amrane, Béjaïa

03000

RECRUITING

CAC-Laghouat, Laghouat

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Société Algérienne de Formation et de Recherche en Oncologie

OTHER